World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
58
Citations
12476
World Ranking
3515
National Ranking
1629

Roger Baxter publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Roger Baxter sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 159 publications — 19th percentile

19% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Roger Baxter D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Roger Baxter sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 58 D-Index — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Best Publications

  • Treatment with Monoclonal Antibodies against Clostridium difficile Toxins

    Israel Lowy;Deborah C. Molrine;Brett A. Leav;Barbara M. Blair

  • Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data.

    James J. Sejvar;Katrin S. Kohl;Jane Gidudu;Anthony Amato

  • Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

    Nicola P. Klein;Joan Bartlett;Ali Rowhani-Rahbar;Bruce Fireman

  • Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

    Steven Black;Henry Shinefield;Roger Baxter;Robert Austrian

  • Measles-Mumps-Rubella-Varicella Combination Vaccine and the Risk of Febrile Seizures

    Nicola P. Klein;Bruce Fireman;W. Katherine Yih;Edwin Lewis

  • Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).

    Brett A. Leav;Barbara M. Blair;Mark Leney;Michael Knauber

  • The Vaccine Safety Datalink: A Model for Monitoring Immunization Safety

    James Baggs;Julianne Gee;Edwin Lewis;Gabrielle Fowler

  • Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based study

    Gary Thomas Ray;Jose Antonio Suaya;Roger Baxter

  • Mycobacterial diseases and antitumour necrosis factor therapy in USA.

    KL Winthrop;R Baxter;L Liu;CD Varley

  • Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias

    Bruce Fireman;Janelle Lee;Ned Lewis;Oliver Bembom

  • The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety

    Michael M. McNeil;Julianne Gee;Eric S. Weintraub;Edward A. Belongia

  • Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.

    Arnd M. Herz;Tara L. Greenhow;Jay Alcantara;John Hansen

  • Comparative Effectiveness of Acellular Versus Whole-Cell Pertussis Vaccines in Teenagers

    Nicola P. Klein;Joan Bartlett;Bruce Fireman;Ali Rowhani-Rahbar

  • Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis

    Roger Baxter;Joan Bartlett;Bruce Fireman;Edwin Lewis

  • Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis

    Roger Baxter;Joan Bartlett;Bruce Fireman;Edwin Lewis

  • Anti-CD20 (rituximab) therapy for anti–IFN-γ autoantibody–associated nontuberculous mycobacterial infection

    Sarah K. Browne;Rifat Zaman;Elizabeth P. Sampaio;Elizabeth P. Sampaio;Kamonwan Jutivorakool;Kamonwan Jutivorakool

  • Long-term Effectiveness of Varicella Vaccine: A 14-Year, Prospective Cohort Study

    Roger Baxter;Paula Ray;Trung N. Tran;Steve Black

  • Waning Tdap Effectiveness in Adolescents.

    Nicola P Klein;Joan Bartlett;Bruce Fireman;Roger Baxter

  • Near Real-Time Surveillance for Influenza Vaccine Safety: Proof-of-Concept in the Vaccine Safety Datalink Project

    Sharon K. Greene;Martin Kulldorff;Edwin M. Lewis;Rong Li

  • Phase III Comparison of an Investigational Quadrivalent Meningococcal Conjugate Vaccine with the Licensed Meningococcal ACWY Conjugate Vaccine in Adolescents

    Lisa A. Jackson;Roger Baxter;Keith Reisinger;Annette Karsten

Frequent Co-Authors

Nicola P. Klein
Nicola P. Klein Kaiser Permanente
Bruce Fireman
Bruce Fireman Kaiser Permanente
Allison L. Naleway
Allison L. Naleway Kaiser Permanente
Edwin Lewis
Edwin Lewis University of Idaho
Edward A. Belongia
Edward A. Belongia Marshfield Clinic
Steven J. Jacobsen
Steven J. Jacobsen Kaiser Permanente
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
Grace M. Lee
Grace M. Lee Stanford University
Frank DeStefano
Frank DeStefano Centers for Disease Control and Prevention
Kathryn M. Edwards
Kathryn M. Edwards Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Roger Baxter

Recently Published Articles